Oklahoma AG announces $5M settlement with CVS Caremark for prescription reimbursement

Mcalesternews
Oklahoma Attorney General Gentner Drummond reached a $5 million settlement with CVS Caremark over claims of underpaying Oklahoma pharmacies.

Summary

Oklahoma Attorney General Gentner Drummond’s office announced a settlement with CVS Caremark for over $5 million regarding allegations that the company was under reimbursing Oklahoma pharmacies for prescriptions. While CVS Caremark did not admit to any wrongdoing, the company agreed to pay the settlement amount and implement reforms to prevent future disputes. The settlement, publicized on Monday, aims to ensure fair reimbursement rates for pharmacies within the state and avoid further legal battles.

(Source:Mcalesternews)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury